KEGG   PATHWAY: rno05150
Entry
rno05150                    Pathway                                
Name
Staphylococcus aureus infection - Rattus norvegicus (rat)
Description
Staphylococcus aureus can cause multiple forms of infections ranging from superficial skin infections to food poisoning and life-threatening infections. The organism has several ways to divert the effectiveness of the immune system: secreting immune modulating proteins that inhibit complement activation and neutrophil chemotaxis or lysis, modulating the sensitivity to cationic antimicrobial peptides (such as defensin) by increasing the positive net charge of its cytoplasmic membrane, and expression of superantigens that prevent development of a normal immune response or cause an emetic response when ingested.
Class
Human Diseases; Infectious disease: bacterial
Pathway map
rno05150  Staphylococcus aureus infection
rno05150

Organism
Rattus norvegicus (rat) [GN:rno]
Gene
266717  Krt9; keratin, type I cytoskeletal 9 [KO:K07604]
287678  Krt23; keratin, type I cytoskeletal 23 [KO:K07604]
287697  Krt35; keratin, type I cuticular Ha5 [KO:K07604]
287698  Krt36; keratin, type I cuticular Ha6 [KO:K07604]
287701  Krt14; keratin, type I cytoskeletal 14 [KO:K07604]
303528  Krt34; keratin, type I cuticular Ha4 [KO:K07604]
360625  Krt12; keratin, type I cytoskeletal 12 [KO:K07604]
360626  Krt19; keratin, type I cytoskeletal 19 [KO:K07604]
287679  Krt40; keratin, type I cytoskeletal 40 [KO:K07604]
303523  Krt39; keratin, type I cytoskeletal 39 [KO:K07604]
450227  Krt33b; keratin, type I cuticular Ha3-II [KO:K07604]
450228  Krt31; keratin, type I cuticular Ha1 [KO:K07604]
450230  Krt32; keratin, type I cuticular Ha2 [KO:K07604]
294853  Krt18; keratin, type I cytoskeletal 18 [KO:K07604]
286912  Krt20; keratin, type I cytoskeletal 20 [KO:K07604]
287699  Krt13; keratin, type I cytoskeletal 13 [KO:K07604]
287700  Krt15; keratin, type I cytoskeletal 15 [KO:K07604]
287702  Krt17; keratin, type I cytoskeletal 17 [KO:K07604]
303519  Krt25; keratin, type I cytoskeletal 25 [KO:K07604]
303527  Krt33a; keratin, type I cuticular Ha3-I [KO:K07604]
303530  Krt16; keratin, type I cytoskeletal 16 [KO:K07604]
450226  Ka11; type I keratin KA11 [KO:K07604]
450229  Krt27; keratin, type I cytoskeletal 27 [KO:K07604]
450231  Krt42; keratin, type I cytoskeletal 42 [KO:K07604]
287675  Krt24; keratin, type I cytoskeletal 24 [KO:K07604]
360623  Krt28; keratin, type I cytoskeletal 28 isoform 2 [KO:K07604]
407758  Krt26; keratin, type I cytoskeletal 26 [KO:K07604]
683212  Krt18l1; keratin, type I cytoskeletal 18-like [KO:K07604]
450225  Krt10; keratin, type I cytoskeletal 10 [KO:K07604]
24367  Fgg; fibrinogen gamma chain precursor [KO:K03905]
24232  C3; complement C3 precursor [KO:K03990]
294257  Cfb; complement factor B precursor [KO:K01335] [EC:3.4.21.47]
54249  Cfd; complement factor D precursor [KO:K01334] [EC:3.4.21.46]
155012  Cfh; complement factor H precursor [KO:K04004]
24548  Mbl1; mannose-binding protein A precursor [KO:K03991]
64668  Mbl2; mannose-binding protein C precursor [KO:K03991]
64023  Masp1; mannan-binding lectin serine protease 1 precursor [KO:K03992] [EC:3.4.21.-]
64459  Masp2; mannan-binding lectin serine protease 2 precursor [KO:K03993] [EC:3.4.21.104]
298566  C1qa; complement C1q subcomponent subunit A precursor [KO:K03986]
29687  C1qb; complement C1q subcomponent subunit B precursor [KO:K03987]
362634  C1qc; complement C1q subcomponent subunit C precursor [KO:K03988]
312705  C1r; complement C1r subcomponent precursor [KO:K01330] [EC:3.4.21.41]
192262  C1s; complement C1s subcomponent precursor [KO:K01331] [EC:3.4.21.42]
24231  C2; complement C2 precursor [KO:K01332] [EC:3.4.21.43]
24233  C4a; complement C4 precursor [KO:K03989]
406161  C4b; complement component 4, gene 2 precursor [KO:K03989]
362119  C5; complement C5 precursor [KO:K03994]
84007  C3ar1; C3a anaphylatoxin chemotactic receptor [KO:K04009]
113959  C5ar1; C5a anaphylatoxin chemotactic receptor 1 [KO:K04010]
295279  Fcgr1a; high affinity immunoglobulin gamma Fc receptor I precursor [KO:K06498]
498276  Fcgr2al1; Fc gamma receptor 2A like 1 [KO:K06472]
134481532  low affinity immunoglobulin gamma Fc region receptor III isoform X1 [KO:K06472]
289211  Fcgr2b; low affinity immunoglobulin gamma Fc region receptor II [KO:K12560]
116591  Fcgr2a; low affinity immunoglobulin gamma Fc region receptor III isoform 1 [KO:K06463]
304966  Fcgr3a; low affinity immunoglobulin gamma Fc region receptor III-A precursor [KO:K06463]
365183  Fcar; immunoglobulin alpha Fc receptor precursor [KO:K06513]
690158  Fpr2; formyl peptide receptor, related sequence 2 [KO:K04173]
690198  Fpr2l2; formyl peptide receptor-related sequence 4 [KO:K04173]
690230  Fpr2l3; formyl peptide receptor-related sequence 7 [KO:K04173]
292419  Fpr2l1; formyl peptide receptor, related sequence 3 [KO:K04173]
292409  Fpr1; fMet-Leu-Phe receptor [KO:K04172]
85253  Plg; plasminogen precursor [KO:K01315] [EC:3.4.21.7]
79126  Cfi; complement factor I precursor [KO:K01333] [EC:3.4.21.45]
363930  Selplg; P-selectin glycoprotein ligand 1 precursor [KO:K06544]
25651  Selp; P-selectin precursor [KO:K06496]
25464  Icam1; intercellular adhesion molecule 1 precursor [KO:K06490]
308995  Itgal; integrin alpha-L precursor [KO:K05718]
25021  Itgam; integrin alpha-M precursor [KO:K06461]
309684  Itgb2; integrin beta-2 precursor [KO:K06464]
83687  Defb1; beta-defensin 1 precursor [KO:K23125]
641633  Defb9; beta-defensin 9 precursor [KO:K23125]
641635  Defb10; beta-defensin 10 precursor [KO:K23125]
641631  Defb2; beta-defensin 2 precursor [KO:K23125]
64389  Defb4; beta-defensin 4 precursor [KO:K21100]
641624  Defb5; beta-defensin 5 precursor [KO:K21100]
641627  Defb14; beta-defensin 14 precursor [KO:K23126]
286995  Defa5; neutrophil antibiotic peptide NP-2 precursor [KO:K05230]
286958  Np4; defensin alpha 4 precursor [KO:K05230]
613220  Defal1; defensin alpha-like protein 1 precursor [KO:K05230]
613224  Defa8; alpha-defensin 8 precursor [KO:K05230]
613225  Defa11; neutrophil defensin 4 precursor [KO:K05230]
498659  RatNP-3b; neutrophil antibiotic peptide NP-3B precursor [KO:K05230]
498658  Defa9; uncharacterized protein LOC498658 precursor [KO:K05230]
613223  Defa6; alpha-defensin 6 precursor [KO:K05230]
290856  Defa24; defensin 5 precursor [KO:K05230]
316010  Camp; cathelicidin antimicrobial peptide precursor [KO:K13916]
291755  Dsg1; desmoglein-1 [KO:K07596]
294274  RT1-DMa; RT1 class II, DM alpha precursor [KO:K06752]
294273  RT1-DMb; RT1 class II, DM beta precursor [KO:K06752]
24984  RT1-DOa; RT1 class II, locus DOa precursor [KO:K06752]
24986  RT1-Ha; RT1 class II, locus Ha precursor [KO:K06752]
294269  RT1-Da; RT1 class II, locus Da precursor [KO:K06752]
294270  RT1-Db1; rano class II histocompatibility antigen, D-1 beta chain precursor [KO:K06752]
309621  RT1-Ba; rano class II histocompatibility antigen, B alpha chain precursor [KO:K06752]
309622  RT1-Bb; rano class II histocompatibility antigen, B-1 beta chain precursor [KO:K06752]
365542  RT1-DOb; RT1 class II, DO beta isoform 1 [KO:K06752]
24981  RT1-Db2; RT1 class II, locus Db2 precursor [KO:K06752]
58949  Ptafr; platelet-activating factor receptor [KO:K04279]
25325  Il10; interleukin-10 precursor [KO:K05443]
Compound
C11596  FMLP
C20898  Lipoteichoic acid
Reference
  Authors
Foster TJ
  Title
Colonization and infection of the human host by staphylococci: adhesion, survival and immune evasion.
  Journal
Vet Dermatol 20:456-70 (2009)
DOI:10.1111/j.1365-3164.2009.00825.x
Reference
  Authors
Foster TJ
  Title
Immune evasion by staphylococci.
  Journal
Nat Rev Microbiol 3:948-58 (2005)
DOI:10.1038/nrmicro1289
Reference
  Authors
Laarman A, Milder F, van Strijp J, Rooijakkers S
  Title
Complement inhibition by gram-positive pathogens: molecular mechanisms and therapeutic implications.
  Journal
J Mol Med 88:115-20 (2010)
DOI:10.1007/s00109-009-0572-y
Reference
  Authors
Rooijakkers SH, van Kessel KP, van Strijp JA
  Title
Staphylococcal innate immune evasion.
  Journal
Trends Microbiol 13:596-601 (2005)
DOI:10.1016/j.tim.2005.10.002
Reference
  Authors
Iwatsuki K, Yamasaki O, Morizane S, Oono T
  Title
Staphylococcal cutaneous infections: invasion, evasion and aggression.
  Journal
J Dermatol Sci 42:203-14 (2006)
DOI:10.1016/j.jdermsci.2006.03.011
Reference
  Authors
Torres BA, Kominsky S, Perrin GQ, Hobeika AC, Johnson HM
  Title
Superantigens: the good, the bad, and the ugly.
  Journal
Exp Biol Med (Maywood) 226:164-76 (2001)
DOI:10.1177/153537020122600303
Reference
  Authors
Atkins KL, Burman JD, Chamberlain ES, Cooper JE, Poutrel B, Bagby S, Jenkins AT, Feil EJ, van den Elsen JM
  Title
S. aureus IgG-binding proteins SpA and Sbi: host specificity and mechanisms of immune complex formation.
  Journal
Mol Immunol 45:1600-11 (2008)
DOI:10.1016/j.molimm.2007.10.021
Reference
  Authors
Silverman GJ, Goodyear CS
  Title
Confounding B-cell defences: lessons from a staphylococcal superantigen.
  Journal
Nat Rev Immunol 6:465-75 (2006)
DOI:10.1038/nri1853
Reference
  Authors
Goodyear CS, Silverman GJ
  Title
Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.
  Journal
Proc Natl Acad Sci U S A 101:11392-7 (2004)
DOI:10.1073/pnas.0404382101
Reference
  Authors
Haupt K, Reuter M, van den Elsen J, Burman J, Halbich S, Richter J, Skerka C, Zipfel PF
  Title
The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b.
  Journal
PLoS Pathog 4:e1000250 (2008)
DOI:10.1371/journal.ppat.1000250
Reference
  Authors
Bokarewa MI, Jin T, Tarkowski A
  Title
Staphylococcus aureus: Staphylokinase.
  Journal
Int J Biochem Cell Biol 38:504-9 (2006)
DOI:10.1016/j.biocel.2005.07.005
Reference
  Authors
Rooijakkers SH, Ruyken M, Roos A, Daha MR, Presanis JS, Sim RB, van Wamel WJ, van Kessel KP, van Strijp JA
  Title
Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases.
  Journal
Nat Immunol 6:920-7 (2005)
DOI:10.1038/ni1235
Reference
  Authors
Rooijakkers SH, Wu J, Ruyken M, van Domselaar R, Planken KL, Tzekou A, Ricklin D, Lambris JD, Janssen BJ, van Strijp JA, Gros P
  Title
Structural and functional implications of the alternative complement pathway C3 convertase stabilized by a staphylococcal inhibitor.
  Journal
Nat Immunol 10:721-7 (2009)
DOI:10.1038/ni.1756
Reference
  Authors
Jongerius I, Kohl J, Pandey MK, Ruyken M, van Kessel KP, van Strijp JA, Rooijakkers SH
  Title
Staphylococcal complement evasion by various convertase-blocking molecules.
  Journal
J Exp Med 204:2461-71 (2007)
DOI:10.1084/jem.20070818
Reference
  Authors
Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM
  Title
Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
  Journal
J Infect Dis 198:125-33 (2008)
DOI:10.1086/588825
Reference
  Authors
Higgins J, Loughman A, van Kessel KP, van Strijp JA, Foster TJ
  Title
Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes.
  Journal
FEMS Microbiol Lett 258:290-6 (2006)
DOI:10.1111/j.1574-6968.2006.00229.x
Reference
  Authors
Laursen NS, Gordon N, Hermans S, Lorenz N, Jackson N, Wines B, Spillner E, Christensen JB, Jensen M, Fredslund F, Bjerre M, Sottrup-Jensen L, Fraser JD, Andersen GR
  Title
Structural basis for inhibition of complement C5 by the SSL7 protein from Staphylococcus aureus.
  Journal
Proc Natl Acad Sci U S A 107:3681-6 (2010)
DOI:10.1073/pnas.0910565107
Reference
  Authors
Ramsland PA, Willoughby N, Trist HM, Farrugia W, Hogarth PM, Fraser JD, Wines BD
  Title
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1.
  Journal
Proc Natl Acad Sci U S A 104:15051-6 (2007)
DOI:10.1073/pnas.0706028104
Reference
  Authors
de Haas CJ, Veldkamp KE, Peschel A, Weerkamp F, Van Wamel WJ, Heezius EC, Poppelier MJ, Van Kessel KP, van Strijp JA
  Title
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.
  Journal
J Exp Med 199:687-95 (2004)
DOI:10.1084/jem.20031636
Reference
  Authors
Prat C, Bestebroer J, de Haas CJ, van Strijp JA, van Kessel KP
  Title
A new staphylococcal anti-inflammatory protein that antagonizes the formyl peptide receptor-like 1.
  Journal
J Immunol 177:8017-26 (2006)
DOI:10.4049/jimmunol.177.11.8017
Reference
  Authors
Bestebroer J, Poppelier MJ, Ulfman LH, Lenting PJ, Denis CV, van Kessel KP, van Strijp JA, de Haas CJ
  Title
Staphylococcal superantigen-like 5 binds PSGL-1 and inhibits P-selectin-mediated neutrophil rolling.
  Journal
Blood 109:2936-43 (2007)
DOI:10.1182/blood-2006-06-015461
Reference
  Authors
Chung MC, Wines BD, Baker H, Langley RJ, Baker EN, Fraser JD
  Title
The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition.
  Journal
Mol Microbiol 66:1342-55 (2007)
DOI:10.1111/j.1365-2958.2007.05989.x
Reference
  Authors
Chavakis T, Hussain M, Kanse SM, Peters G, Bretzel RG, Flock JI, Herrmann M, Preissner KT
  Title
Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes.
  Journal
Nat Med 8:687-93 (2002)
DOI:10.1038/nm728
Reference
  Authors
Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M
  Title
Gram-positive three-component antimicrobial peptide-sensing system.
  Journal
Proc Natl Acad Sci U S A 104:9469-74 (2007)
DOI:10.1073/pnas.0702159104
Reference
  Authors
Sieprawska-Lupa M, Mydel P, Krawczyk K, Wojcik K, Puklo M, Lupa B, Suder P, Silberring J, Reed M, Pohl J, Shafer W, McAleese F, Foster T, Travis J, Potempa J
  Title
Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases.
  Journal
Antimicrob Agents Chemother 48:4673-9 (2004)
DOI:10.1128/AAC.48.12.4673-4679.2004
Reference
  Authors
Fraser JD, Proft T
  Title
The bacterial superantigen and superantigen-like proteins.
  Journal
Immunol Rev 225:226-43 (2008)
DOI:10.1111/j.1600-065X.2008.00681.x
Reference
  Authors
Yamaguchi T, Nishifuji K, Sasaki M, Fudaba Y, Aepfelbacher M, Takata T, Ohara M, Komatsuzawa H, Amagai M, Sugai M
  Title
Identification of the Staphylococcus aureus etd pathogenicity island which encodes a novel exfoliative toxin, ETD, and EDIN-B.
  Journal
Infect Immun 70:5835-45 (2002)
DOI:10.1128/IAI.70.10.5835-5845.2002
Reference
  Authors
Pazgier M, Hoover DM, Yang D, Lu W, Lubkowski J
  Title
Human beta-defensins.
  Journal
Cell Mol Life Sci 63:1294-313 (2006)
DOI:10.1007/s00018-005-5540-2
Reference
  Authors
Zhang Q, Mousdicas N, Yi Q, Al-Hassani M, Billings SD, Perkins SM, Howard KM, Ishii S, Shimizu T, Travers JB
  Title
Staphylococcal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor.
  Journal
J Clin Invest 115:2855-61 (2005)
DOI:10.1172/JCI25429
Reference
  Authors
Lehrer RI
  Title
Primate defensins.
  Journal
Nat Rev Microbiol 2:727-38 (2004)
DOI:10.1038/nrmicro976
Related
pathway
rno04610  Complement and coagulation cascades
rno04660  T cell receptor signaling pathway
rno04662  B cell receptor signaling pathway
KO pathway
ko05150   
LinkDB

DBGET integrated database retrieval system